Q1 2024 Holdings
Filed 2024-05-15 | 50 holdings | $2.4B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $289.2M | 12,226,943 | 12.2% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $175.9M | 988,460 | 7.4% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $163.2M | 6,495,392 | 6.9% |
| Hillevax Inc | COM | 43157M102 | $162.7M | 9,781,472 | 6.9% |
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $124.1M | 3,131,008 | 5.2% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $107.4M | 10,109,279 | 4.5% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $105.6M | 3,415,604 | 4.5% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $94.9M | 2,190,179 | 4.0% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $87.1M | 8,785,284 | 3.7% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $77.8M | 1,139,405 | 3.3% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $65.0M | 1,787,527 | 2.7% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $60.3M | 3,303,567 | 2.5% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $57.0M | 4,142,855 | 2.4% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $52.0M | 885,165 | 2.2% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $48.9M | 785,000 | 2.1% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $48.5M | 3,014,349 | 2.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $43.7M | 3,687,867 | 1.8% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $42.1M | 1,561,230 | 1.8% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $37.5M | 875,667 | 1.6% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $36.4M | 2,471,704 | 1.5% |
| Aerovate Therapeutics Inc | COM | 008064107 | $35.6M | 1,204,867 | 1.5% |
| CG Oncology Inc(CGON) | COM | 156944100 | $33.8M | 770,000 | 1.4% |
| Merus N V | COM | N5749R100 | $33.6M | 746,479 | 1.4% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $32.1M | 997,455 | 1.4% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $29.5M | 4,623,324 | 1.2% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $27.0M | 629,194 | 1.1% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $25.5M | 7,381,090 | 1.1% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $24.8M | 1,148,591 | 1.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $22.9M | 1,455,837 | 1.0% |
| Pepgen Inc(PEPG) | COM | 713317105 | $22.1M | 1,502,788 | 0.9% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $20.3M | 899,700 | 0.9% |
| Savara Inc(SVRA) | COM | 805111101 | $19.9M | 4,000,000 | 0.8% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $16.6M | 393,000 | 0.7% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $15.3M | 523,166 | 0.6% |
| Adverum Biotechnologies Inc(ADVMCHF) | COM | 00773U108 | $15.1M | 1,069,244 | 0.6% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $14.9M | 2,816,294 | 0.6% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $13.6M | 832,220 | 0.6% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $13.3M | 1,952,857 | 0.6% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $12.8M | 2,867,750 | 0.5% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $11.8M | 285,331 | 0.5% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $11.6M | 1,000,000 | 0.5% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $8.7M | 470,338 | 0.4% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $6.3M | 936,576 | 0.3% |
| Intellia Therapeutics Inc(NTLA) | COM | 45826J105 | $5.6M | 203,684 | 0.2% |
| Newamsterdam Pharma Company | *W EXP 11/22/202 | N62509117 | $5.5M | 500,333 | 0.2% |
| An2 Therapeutics Inc(ANTX) | COM | 037326105 | $4.5M | 1,388,889 | 0.2% |
| Metagenomi Inc(MGX) | COM | 59102M104 | $2.9M | 279,025 | 0.1% |
| Gritstone BIO Inc(2JQ) | COM | 39868T105 | $2.6M | 1,030,878 | 0.1% |
| Bluebird BIO Inc | COM | 09609G100 | $2.2M | 1,709,907 | 0.1% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $327.8K | 264,377 | 0.0% |